A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
Titel:
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
Auteur:
Johnston, Stephen R. D. Semiglazov, Vladimir F. Manikhas, George M. Spaeth, Dominique Romieu, Gilles Dodwell, David J. Wardley, Andrew M. Neven, Patrick Bessems, Annick Park, Youn C. Porre, Peter M. De Perez Ruixo, Juan J. Howes, Angela J.